MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Caregiver Contribution to self-care in people with Parkison’s Disease: a meta-synthesis

    C. Tedesco, M. Petralito, R. Caruso, I. Milani, G. Pucciarelli (Rome, Italy)

    Objective: The aim of the meta-synthesis is to explore the literature to understand the role of caregiver contribution to the self-care in people with Parkinson’s…
  • 2025 International Congress

    Implementation of the Distress Thermometer in a Movement Disorder Clinic

    R. Hoe, M. Low, L. Zhou, L. Fu, E. Ng, W. Li, W. Ng, V. Lim, S. Mathivannan, W. Lee, W. Tapin, S. Tan, N. Baharudin, T. Leong, S. Neo, A. Ng (Singapore, Singapore)

    Objective: To present the findings from the implementation of widespread screening for psychosocial distress using a distress thermometer (DT) in a Movement Disorder clinic. Background:…
  • 2025 International Congress

    Spinocerebellar Ataxia 17 Presenting with Childhood Seizures and Mesial Temporal Lobe Sclerosis

    E. Levoir, Y. Bronstein, P. Hickey, C. Fong (Los Angeles, USA)

    Objective: To report an unusual phenotype of spinocerebellar ataxia 17 (SCA17) with childhood onset epilepsy evolving into asymmetric motor impairment with features of dystonia and…
  • 2025 International Congress

    Turning Points in Disease Progression: Detecting MRI Biomarker Transitions in SCA3 Using Longitudinal Data

    M. Ferreira, P. Wegner, T. Klockgether, J. Faber (Bonn, Germany)

    Objective: This study aims to identify data-driven turning points in MRI biomarkers of SCA3 to characterize region-specific disease transitions and inform early intervention strategies. Background: SCA3…
  • 2025 International Congress

    Quantifying ataxia in RFC1-related disorder using wearable devices

    J. Franco Neiva, C. Lobo Cardoso, I. Colombani, N. Serra Santos, F. Lima, P. Assis Matos, R. Paes Guimarães, A. Muro Martinez, J. Pedroso, O. Povoas Barsottini, M. França Jr, W. Marques Jr, T. Rezende (Campinas, Brazil)

    Objective: We aimed to compare standing balance and postural conditions between RFC1 patients and healthy controls. Background: RFC1-related ataxia is a progressive neurological disorder affecting…
  • 2025 International Congress

    Ataxia, the initial symptom in a patient with Huntington’s Disease and Acquired (non-Wilsonian) Hepatocerebral Degeneration

    V. Montero, N. Valdés, á. Pontoni, P. Salles (Santiago de Chile, Chile)

    Objective: To describe a patient with Huntington disease and acquired (non-Wilsonian) hepatocerebral degeneration (AHD) presenting with ataxia. Background: AHD is a neurological disorder that occurs…
  • 2025 International Congress

    Upper Limb Tremor Suppression Using Targeted High Frequency Peripheral Nerve Stimulation

    V. Ganesh, X. Xue, D. Roque, N. Sharma (Raleigh, USA)

    Objective: In this work, we aimed to suppress wrist tremors in individuals affected by Parkinson's disease (PD) and essential tremor (ET) using targeted, high frequency…
  • 2025 International Congress

    Staged Bilateral MRI-Guided Focused Ultrasound Thalamotomy in Essential Tremor a Single Institution Experience of 26 Patients

    N. Pertsch, K. Sakakura, YJ. Ahn, D. Kim, J. Mueller, L. Chiu, J. Varela, S. Patel, J. Pearce, N. Patel, S. Sani (Chicago, USA)

    Objective: We describe tremor outcomes, adverse effects, and impact to quality of life after staged bilateral MRI-Guided Focused Ultrasound (MRgFUS) Thalamotomy for Essential Tremor. Background:…
  • 2025 International Congress

    Subthalamotomy and thalamotomy using MgFUS: Retrospective review of 9 years of treating Parkinson’s disease and Essential Tremor.

    C. Del Toro-Pérez, R. Martínez-Fernández, E. Natera-Villalba, R. Rodriguez-Rojas, J. Pineda-Pardo, C. Gasca Salas, M. Matarazzo, JA. Obeso Inchausti (Madrid, Spain)

    Objective: To report a 9-year single-center experience using MRgFUS thermoablation for movement disorders. Background: Over 22000 patients with Essential Tremor (ET), Parkinson´s disease (PD) and…
  • 2025 International Congress

    Personalised Success: Evaluating Hemifacial Spasm Treatment with Goal Attainment Scale

    S. Maytharakcheep, O. Phokaewvarangkul, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To assess the effectiveness of botulinum toxin A (BoNTA) therapy in treating  hemifacial spasm (HFS) patients using Goal Attainment Scale (GAS). Background: HFS is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley